|
"葉宏仁"的相關文件
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 國立虎尾科技大學 |
2012 |
失效模式與效應分析於射出成型製程之研究
|
葉宏仁 |
| 國立臺灣大學 |
2009 |
Heparanase Inhibitor Pi-88 as Adjuvant Therapy for Hepatocellular Carcinoma after Curative Resection: A Randomized Phase Ii Trial for Safety and Optimal Dosage
|
劉俊人; 李伯皇; 胡瑞恆; 吳誠中; 鄭隆賓; 林炳文; 莫景棠; 葉宏仁; 何明志; 楊勝舜; 陳培哲; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 國立臺灣大學 |
2009 |
Il-10 Promoter Gene Polymorphisms and Sustained Response to Combination Therapy in Taiwanese Chronic Hepatitis C Patients
|
莊淨媛; 楊勝舜; 張繼森; 葉宏仁; 高嘉宏; CHUANG, JING-YUAN; YANG, SHENG-SHUN; CHANG, CHI-SEN; YEH, HONG-ZEN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2006 |
Changes of Soluble Cd26 and Cd30 Levels Correlate with Response to Interferon Plus Ribavirin Therapy in Patients with Chronic Hepatitis C
|
楊勝舜; 傅令嫻; 張繼森; 葉宏仁; 陳儉鏗; 高嘉宏; YANG, SHENG-SHUN; FU, LIN-SHIEN; CHANG, CHI-SEN; YEH, HONG-ZEN; CHEN, GRAN-HUM; KAO, JIA-HORNG |
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
|
